MERLO, MARCO
 Distribuzione geografica
Continente #
NA - Nord America 33.094
AS - Asia 19.302
EU - Europa 18.943
SA - Sud America 2.648
Continente sconosciuto - Info sul continente non disponibili 1.840
AF - Africa 578
OC - Oceania 56
Totale 76.461
Nazione #
US - Stati Uniti d'America 32.189
SG - Singapore 6.997
IT - Italia 6.706
CN - Cina 4.367
PL - Polonia 2.249
BR - Brasile 1.962
VN - Vietnam 1.956
HK - Hong Kong 1.717
DE - Germania 1.642
SE - Svezia 1.566
FR - Francia 1.163
BD - Bangladesh 1.149
KR - Corea 1.095
GB - Regno Unito 919
NL - Olanda 843
FI - Finlandia 730
RU - Federazione Russa 716
UA - Ucraina 546
IN - India 451
CA - Canada 450
BG - Bulgaria 393
IE - Irlanda 354
TR - Turchia 321
AR - Argentina 217
JP - Giappone 212
MX - Messico 203
ES - Italia 201
CH - Svizzera 197
AT - Austria 184
MA - Marocco 147
ID - Indonesia 142
ZA - Sudafrica 135
IQ - Iraq 113
EC - Ecuador 98
CO - Colombia 92
CL - Cile 82
PK - Pakistan 79
BE - Belgio 78
SA - Arabia Saudita 72
VE - Venezuela 70
EG - Egitto 67
RO - Romania 64
PH - Filippine 63
CZ - Repubblica Ceca 56
GR - Grecia 56
IR - Iran 53
AE - Emirati Arabi Uniti 51
PE - Perù 49
PT - Portogallo 47
AU - Australia 44
UZ - Uzbekistan 41
JO - Giordania 40
CR - Costa Rica 39
MY - Malesia 38
PY - Paraguay 38
KE - Kenya 37
SN - Senegal 37
LT - Lituania 36
TH - Thailandia 36
KZ - Kazakistan 34
DZ - Algeria 32
TW - Taiwan 31
AZ - Azerbaigian 30
IL - Israele 30
JM - Giamaica 29
RS - Serbia 26
TN - Tunisia 26
EU - Europa 25
NP - Nepal 25
HN - Honduras 24
UY - Uruguay 23
TT - Trinidad e Tobago 21
NI - Nicaragua 20
OM - Oman 20
AL - Albania 19
LV - Lettonia 19
PA - Panama 19
KG - Kirghizistan 17
DO - Repubblica Dominicana 16
HU - Ungheria 16
SK - Slovacchia (Repubblica Slovacca) 16
BO - Bolivia 15
BY - Bielorussia 14
DK - Danimarca 14
GE - Georgia 14
GT - Guatemala 14
SV - El Salvador 14
ET - Etiopia 13
PR - Porto Rico 13
SI - Slovenia 13
CY - Cipro 12
KW - Kuwait 12
NG - Nigeria 12
HR - Croazia 11
LK - Sri Lanka 11
TG - Togo 11
MD - Moldavia 10
LB - Libano 9
NO - Norvegia 9
NZ - Nuova Zelanda 9
Totale 74.443
Città #
Ashburn 4.355
Singapore 4.185
San Jose 2.158
Fairfield 2.069
Chandler 1.800
Warsaw 1.798
Hong Kong 1.640
Woodbridge 1.502
Council Bluffs 1.254
Houston 1.122
Ann Arbor 1.108
Seoul 1.067
Hefei 1.043
Beijing 1.004
Trieste 958
Seattle 914
Wilmington 881
Chicago 781
Cambridge 720
Los Angeles 696
Dallas 682
Milan 642
Boardman 635
Ho Chi Minh City 605
Columbus 565
Jacksonville 551
Princeton 466
Santa Clara 442
Hanoi 436
New York 423
Helsinki 400
Lauterbourg 399
Rome 397
Sofia 382
London 371
Zgierz 363
Munich 362
Dublin 344
Frankfurt am Main 282
Moscow 264
The Dalles 256
Buffalo 255
Phoenix 207
São Paulo 203
Izmir 189
Amsterdam 182
North Bergen 179
Dearborn 164
Naples 162
Orem 142
San Diego 132
Tokyo 132
Montreal 131
Salt Lake City 125
Atlanta 124
Düsseldorf 121
Toronto 117
Bern 115
Nuremberg 113
Bologna 110
Da Nang 106
Vienna 106
Casablanca 105
Lappeenranta 104
Grafing 103
Turin 103
Denver 99
Washington 99
Venice 94
Florence 93
Shanghai 92
Redondo Beach 86
Turku 86
Brooklyn 85
Guangzhou 85
Chennai 84
Haiphong 70
Bremen 69
Brussels 68
Dong Ket 68
Miano 67
Boston 66
Stockholm 64
Verona 64
Johannesburg 63
San Francisco 63
Memphis 61
Mexico City 61
Poplar 59
Venezia 59
Bari 57
Tampa 57
Des Moines 55
Manchester 54
Mumbai 54
Paris 54
Rio de Janeiro 54
Udine 54
Jinan 53
Redwood City 53
Totale 46.202
Nome #
Does Ectopic Beats Bring More Discriminatory Information to Diagnose Ischemic Heart Disease? 482
Arresto cardiaco extraospedaliero: le competenze degli studenti dell’Università degli Studi di Trieste sulle manovre rianimatorie e l’utilizzo del defibrillatore automatico esterno 477
Natural History of Dilated Cardiomyopathy in Children 441
Arrhythmogenic Phenotype in Dilated Cardiomyopathy: Natural History and Predictors of Life-Threatening Arrhythmias 432
Role of Titin Missense Variants in Dilated Cardiomyopathy 428
Inquadramento e gestione delle cardiomiopatie: il protocollo della Cardiologia di Trieste 419
Sex- and age-related differences in the management and outcomes of chronic heart failure: an analysis of patients from the ESC HFA EORP Heart Failure Long-Term Registry 418
Miocardite, cardiomiopatia infiammatoria e perimiocardite: possiamo fare ordine? 417
Persistent recovery of normal left ventricular function and dimension in idiopathic dilated cardiomyopathy during long‐term follow‐up: does real healing exist? 416
Filamin C Truncation Mutations Are Associated With Arrhythmogenic Dilated Cardiomyopathy and Changes in the Cell–Cell Adhesion Structures 409
Reverse remodeling in Dilated Cardiomyopathy: Insights and future perspectives 383
I dieci punti che il cardiologo deve conoscere su scintigrafia miocardica con traccianti ossei, amiloidosi e cuore 381
Conflicting gender-related differences in the natural history of patients with idiopathic dilated cardiomyopathy 371
Genetic Risk of Arrhythmic Phenotypes in Patients With Dilated Cardiomyopathy 369
Early diagnosis, disease stage and prognosis in wild-type transthyretin amyloid cardiomyopathy: The DIAMOND study 344
Documento di consenso Società Italiana di Cardiologia- Società Italiana di Nefrologia: Ruolo dell’asse cardio-renale nella prevenzione e trattamento delle patologie cardiovascolari – Parte II: Dalle strategie di prevenzione al trattamento del paziente con coinvolgimento cardio-renale 338
Dilated Cardiomyopathy With Mid-Range Ejection Fraction at Diagnosis: Characterization and Natural History 336
La cardiomiopatia dilatativa come malattia dinamica: storia naturale, rimodellamento inverso e stratificazione prognostica 333
Impact of Aging on Heart Rate Variability Properties of Healthy Subjects 324
High prevalence of subtle systolic and diastolic dysfunction in genotype-positive phenotype-negative relatives of dilated cardiomyopathy patients 322
Exercise oxygen pulse kinetics in patients with hypertrophic cardiomyopathy 319
Deleterious impact of mild anemia on survival of young adult patients (age 45 ± 14 years) with idiopathic dilated cardiomyopathy: data from the Trieste Cardiomyopathies Registry. 313
Contemporary etiology and prognosis of dilated non-ischemic cardiomyopathy 305
Pathophysiology of dilated cardiomyopathy: from mechanisms to precision medicine 304
Are nonsustained ventricular tachycardias predictive of major arrhythmias in patients with dilated cardiomyopathy on optimal medical treatment? 303
Dieci quesiti in tema di miocardite eosinofila [Ten questions about eosinophilic myocarditis] 301
Com'è cambiata la storia naturale della cardiomiopatia dilatativa? 297
Cardiac amyloidosis: a changing epidemiology with open challenges 295
Hot Phases Cardiomyopathy: Pathophysiology, Diagnostic Challenges, and Emerging Therapies 289
A national survey on prevalence of possible echocardiographic red flags of amyloid cardiomyopathy in consecutive patients undergoing routine echocardiography: study design and patients characterization - the first insight from the AC-TIVE Study 288
Infiltrative/storage cardiomyopathies: Clinical assessment and imaging in diagnosis and patient management 285
Predicting device failure after percutaneous repair of functional mitral regurgitation in advanced heart failure: Implications for patient selection 285
Prognostic impact of short-term changes of E/E' ratio and left atrial size in dilated cardiomyopathy 281
Arrhythmic Risk Stratification in Patients With Idiopathic Dilated Cardiomyopathy 281
Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12 440 patients of the ESC Heart Failure Long-Term Registry 280
Historical Terminology, Classifications, and Present Definition of DCM. 280
Atrial fibrillation in dilated cardiomyopathy: Outcome prediction from an observational registry 280
Early occurrence of drug intolerance as risk factor during follow-up in patients with acute coronary syndrome or coronary revascularization 278
Performance of Prognostic Risk Scores in Chronic Heart Failure Patients Enrolled in the European Society of Cardiology Heart Failure Long-Term Registry 275
Other cardiomyopathies: Clinical assessment and imaging in diagnosis and patient management 272
Acute Hemodynamic Response to Cardiac Resynchronization in Dilated Cardiomyopathy: Effect on Late Mitral Regurgitation 270
Association of Tricuspid Regurgitation With Outcome in Acute Heart Failure 267
Influence of Aging on Short- and Long-term Heart Rate Variability in Patients with Heart Failure 267
Interchangeability of B type natriuretic peptide measurements in lithium heparin and K2EDTA: agreement between matrices and differences in diagnostic accuracy. 266
null 266
Comparison of different prediction models for the indication of implanted cardioverter defibrillator in patients with arrhythmogenic right ventricular cardiomyopathy 265
Early Improvement of Functional Mitral Regurgitation in Patients With Idiopathic Dilated Cardiomyopathy 264
Comparison of Patient Characteristics and Course of Hypertensive Hypokinetic Cardiomyopathy Versus Idiopathic Dilated Cardiomyopathy 264
Outcome of the multidimensional prognostic index in ultra-octogenarian patients hospitalized for cardiovascular diseases 264
Chapter 6: Clinical Presentation, Spectrum of Disease, and Natural History 264
Association between mutation status and left ventricular reverse remodelling in dilated cardiomyopathy 262
HRV analysis in CHF patients with different etiologies by means of spectral and nonlinear indexes 261
Clinical characterization and natural history of chemotherapy-induced dilated cardiomyopathy 259
Left bundle branch block in dilated cardiomyopathy with intermediate left ventricular dysfunction: clinical phenotyping and outcome correlates 258
ST-elevation myocardial infarction with reduced left ventricular ejection fraction: Insights into persisting left ventricular dysfunction. A pPCI-registry analysis 258
Arrhythmic risk stratification by cardiac magnetic resonance tissue characterization: disclosing the arrhythmic substrate within the heart muscle 255
Chapter 12: Prognostic Stratification and Importance of Follow-Up 253
Myocarditis in Clinical Practice 252
Emergency Surgery and Cardiac Devices 252
Treatment of Functional Mitral Regurgitation in Heart Failure 252
Genetics of Dilated Cardiomyopathy: Clinical Implications 252
Prevalence and prognostic significance of ischemic late gadolinium enhancement pattern in non-ischemic dilated cardiomyopathy 250
Cardiovascular aging: the unveiled enigma from bench to bedside 250
ECG in dilated cardiomyopathy: Specific findings and long-term prognostic significance 250
Chapter 15: Dilated Cardiomyopathy at the Crossroad: Multidisciplinary Approach 249
Global longitudinal strain by CMR improves prognostic stratification in acute myocarditis presenting with normal LVEF 248
Prognostic predictors in arrhythmogenic right ventricular cardiomyopathy: results from a 10-year registry. 248
Prognostic Value of Global Longitudinal Strain-Based Left Ventricular Contractile Reserve in Candidates for Percutaneous Correction of Functional Mitral Regurgitation: Implications for Patient Selection 248
Idiopathic dilated cardiomyopathy and persistent viral infection: Lack of association in a controlled study using a quantitative assay. 244
Early right ventricular response to cardiac resynchronization therapy: Impact on clinical outcomes 244
Prevalence and prognostic significance of left ventricular reverse remodeling in dilated cardiomyopathy receiving tailored medical treatment. 243
Evolving concepts in dilated cardiomyopathy 243
Incidence and risk factors for pacemaker implantation in light-chain and transthyretin cardiac amyloidosis 242
Myocarditis evolving in cardiomyopathy: When genetics and offending causes work together 242
Phenotypic Expression, Natural History and Risk Stratification of Cardiomyopathy Caused by Filamin C Truncating Variants 240
Left Atrial Reverse Remodeling in Dilated Cardiomyopathy 239
Echocardiographic evaluation of systolic and mean pulmonary artery pressure in the follow-up of patients with pulmonary hypertension. 239
Usefulness of Addition of Magnetic Resonance Imaging to Echocardiographic Imaging to Predict Left Ventricular Reverse Remodeling in Patients With Nonischemic Cardiomyopathyhttps://arts.units.it/submit?resume=115962# 238
The Prognostic Impact of the Evolution of RV Function in Idiopathic DCM 237
Titin and desmosomal genes in the natural history of arrhythmogenic right ventricular cardiomyopathy 236
Lifelong arrhythmic risk stratification in arrhythmogenic right ventricular cardiomyopathy: distribution of events and impact of periodical reassessment. 235
Chapter 14: Unresolved Issues and Future Perspectives 235
Genetic and Phenotypic Characterization of Nexilin (NEXN)-Related Cardiomyopathy: Results From a Multicentric Study 235
Cardiac Magnetic Resonance Feature-Tracking Identifies Preclinical Abnormalities in Hypertrophic Cardiomyopathy Sarcomere Gene Mutation Carriers 234
Predictors for Restoration of Normal Left Ventricular Function in Response to Cardiac Resynchronization Therapy Measured at Time of Implantation. 234
Arrhythmogenic right ventricular cardiomyopathy: Arrhythmogenic right ventricular cardiomyopathy: Clinical assessment and differential diagnosis 234
Prognostic value of cardiopulmonary exercise testing in Idiopathic Dilated Cardiomyopathy 233
Arrhythmic risk stratification in patients with dilated cardiomyopathy and intermediate left ventricular dysfunction 233
ICD replacement in patients with intermediate left ventricular dysfunction under optimal medical treatment 232
Regional Variation in RBM20 Causes a Highly Penetrant Arrhythmogenic Cardiomyopathy 230
Fulminant Versus Acute Nonfulminant Myocarditis in Patients With Left Ventricular Systolic Dysfunction 230
DEFINITION, CLASSIFICATION, EPIDEMIOLOGY, AND CLINICAL RELEVANCE OF CARDIOMYOPATHIES. 229
Clinical Echocardiography and Other Imaging Techniques in Cardiomyopathies 228
Role of the Electrocardiogram in Differentiating Genetically Determined Dilated Cardiomyopathy from Athlete's Heart 227
Usefulness of high-dose intravenous human immunoglobulins treatment for refractory recurrent pericarditis. 226
Long-Term Evolution and Prognostic Stratification of Biopsy-Proven Active Myocarditis 226
Persistent left ventricular dysfunction after acute lymphocytic myocarditis: Frequency and predictors 226
Chapter 3: Pathophysiology 226
Association of Titin Variations with Late-Onset Dilated Cardiomyopathy 226
Relative survival in dilated cardiomyopathy: a stratification study of long-term outcome to evaluate life insurance cover. 225
Totale 28.356
Categoria #
all - tutte 227.270
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 227.270


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.930 0 0 249 252 187 307 153 94 379 336 235 738
2022/20235.556 425 710 545 844 464 872 84 467 589 120 277 159
2023/20244.941 362 263 224 363 434 522 769 722 124 188 531 439
2024/202511.760 327 646 1.084 959 978 940 742 693 1.311 1.589 1.148 1.343
2025/202631.344 3.375 1.774 2.570 2.837 2.390 2.442 3.779 1.155 3.320 3.840 2.247 1.615
2026/20274.799 1.695 1.886 1.218 0 0 0 0 0 0 0 0 0
Totale 76.461